In the era of Internet +, the country's attention to the digital economy continues to increase, and the digital demand of China's pharmaceutical industry also highlights. With the rising tide of digitalization, coupled with the impact of the global epidemic storm, in order to gain a firm foothold in the fierce market competition and even gain greater competitive advantages, major biomedical leading enterprises have opened the digital transformation.

Ride the digital wind

The pharmaceutical industry has ushered in innovative changes

At present, with the improvement of China's global influence, the biopharmaceutical industry is booming, and biopharmaceutical enterprises are facing more and more challenges from all directions. To innovate and develop pharmaceutical enterprises, digital support has become the key. However, the pharmaceutical digital industry is different from the consumer Internet, which requires enterprises to have a strong digital innovation ability, but also requires enterprises to have enough in-depth cognition and experience precipitation of the pharmaceutical industry.

ClinChoice Kunling (hereinafter referred to as "Kunling") is a clinical CRO dedicated to providing high-quality one-stop services for biomedical and medical device customers. Since its establishment, through its own organic growth and strategic mergers and acquisitions, Kunling has more than 3,500 clinical research and development professionals worldwide, covering hot cities and regions of pharmaceutical research and development at home and abroad, and has developed into a local clinical CRO enterprise model supporting innovative pharmaceutical device research and development. With the advent of the digital economy era, the pace of change in the pharmaceutical industry is accelerating, and IT technologies such as cloud computing, big data, and AI are increasingly changing the R&D and production model, business process and business model of pharmaceutical companies. As a well-known pharmaceutical company that conducts clinical research and development of innovative pharmaceutical devices for the world, Kunling realizes service transition on the basis of continuous technology upgrading, and supports intelligent decision-making, business innovation expansion and digital development between the headquarters and multiple branches with excellent "IT hard strength" through upgrading the group's IT network infrastructure.

SD-WAN Intelligent dual network

Upgrade the IT infrastructure platform of pharmaceutical companies

Guanglian is a senior MSP with 20 years of experience in intelligent network services. In recent years, it has focused on the pharmaceutical field and launched SD-WAN pharmaceutical intelligent network solutions, which have successfully helped well-known pharmaceutical companies such as Boteng, North and South Pharmaceutical Company and Qilu Pharmaceutical to create Internet smart pharmaceutical services.
Based on the current network status of Kunling, the optical link realizes unified internal network management through SD-WAN intelligent dual-network solution, and adopts dual-device hot backup architecture for CE/PE. IT upgrades a safe, reliable, stable, flexible and scalable intelligent network IT infrastructure platform for Kunling Pharmaceutical's R&D, production, internal office and other application scenarios. Fully empower the digital transformation of the pharmaceutical business.

Dual-network dual-use: Each point adopts dual-system dual-network + hot/cold backup + remote escape architecture to achieve hardware and line load balancing and redundancy backup, and further ensure the stability of network access in the Kunling system.
QOS application assurance: Intelligent traffic diversion policies are used to automatically filter Intranet and Intranet traffic, ensure core service bandwidth, improve link bandwidth utilization, and reduce enterprise bandwidth costs.
Simplified operation and maintenance: Light Link provides long-term and efficient active operation and maintenance services for Kunling, reduces the operation and maintenance pressure of enterprises, and creates a high-quality network environment for the development of pharmaceutical business.

Three service values

Enable Kunling pharmaceutical data intelligence innovation

Deploy SD-WAN intelligent dual network, realize the upgrade and optimization of Kunling's IT architecture, and provide a solid network foundation support for enterprises to accelerate the digital strategic layout of pharmaceutical business.
High-quality intelligent network connection, secure data transmission, and promote enterprises to build a secure and robust network platform.
Enable Kunling to develop in the new service-oriented digital intelligence direction of medical information integration, business specialization, fine management and intelligent operation.